Alphatec Hlds

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Alphatec (ATEC) posts robust earnings, eyes growth through innovation

Alphatec (ATEC) delivered strong financial results in Q4 2022, with revenue growth, operational improvements, and a positive outlook for 2023.
The company's focus on innovation, surgeon adoption, and profitability underscores its strategic approach to sustainable growth and market leadership.
ATEC faces challenges in margin improvement, achieving EBITDA targets, and navigating competitive consolidation in the spine space.
However, the company remains optimistic, leveraging opportunities in procedural expansion, technological innovation, and international market expansion for future success.

Alphatec (ATEC) reports stellar Q1 growth and strategic acquisitions

Alphatec (ATEC) showcased robust revenue growth, strategic acquisitions, and a focus on enhancing procedural efficiency and surgeon adoption.
While challenges exist in achieving EBITDA break-even and expanding margins, ATEC's strong performance and growth outlook present promising opportunities.
The company's emphasis on technology integration, international expansion, and increasing robotics utilization positions ATEC for future success.

Alphatec (ATEC) reports robust Q2 growth and eyes international expansion

Alphatec's Q2 performance reflects strong revenue growth, margin expansion, and market share gains driven by strategic initiatives in spine surgery. The company's focus on innovation, surgeon adoption, and geographic expansion positions it well for future growth and success in the spine market.

Alphatec (ATEC) reports robust Q3 earnings, eyes growth opportunities

Alphatec (ATEC) delivered strong financial performance in Q3 2023, driven by revenue growth, positive adjusted EBITDA, and strategic initiatives.
The company's strengths lie in its spine surgery focus, new product launches, and advancements in informatics and robotic integration.
Challenges include managing risks, balancing growth with profitability, and navigating market disruptions, while opportunities exist in expansion and technology integration.

Alphatec (ATEC) reports robust Q4 performance, eyes international expansion

Alphatec (ATEC) had a strong Q4 2023, focusing on clinical excellence and market share growth. Challenges include managing debt and sustaining momentum. Opportunities lie in international expansion and innovative product launches.

Alphatec Hlds (ATEC) reports robust Q1 performance and growth outlook

Alphatec Hlds (ATEC) delivered a strong Q1 2024 performance with significant revenue growth, surgeon adoption, and sales team confidence, underpinned by a focus on innovation and market expansion.
While facing challenges in debt management and profitability, the company's strategic outlook, financial strength, and growth drivers position it well for future success and sustained growth.
By capitalizing on opportunities in technology integration, international expansion, and market share expansion, Alphatec is poised to drive continued innovation and value creation in the spine surgery market.

Alphatec Hlds (ATEC) reports robust Q2 growth and eyes Japan expansion

Alphatec Hlds (ATEC) delivered strong financial results in Q2 2024, showcasing growth in revenue, profitability, and surgeon engagement, while focusing on innovation and clinical distinction.
The company faces challenges in achieving cash flow break-even, entering new markets like Japan, and expanding into deformity surgery, but sees opportunities in market growth and technological advancements.
Overall, Alphatec Hlds (ATEC) remains committed to advancing spine surgery through technology, attracting surgeons to advanced tools, and driving sustainable growth through strategic initiatives.

Alphatec (ATEC) excels in Q3 earnings, eyes growth opportunities

Alphatec (ATEC) reported a robust Q3 performance marked by strong revenue growth and positive adjusted EBITDA, driven by surgical and EOS revenue increases. While challenges in gross margin and cash flow breakeven exist, the company remains optimistic about long-term financial commitments and revenue growth. ATEC's strategic focus on value creation, surgeon adoption, and innovation positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Completes InVictus System Allowing Seamless Spinal Fixation from Occiput to Ilium Completes InVictus System Allowing Seamless Spinal Fixation from Occiput to Ilium

ATEC Furthers Clinical Distinction with Launch of InVictus® OCT Posterior Fixation System for the Cervical and Thoracic Spine

Alphatec Holdings, Inc. (ATEC) CEO Patrick Miles on Q4 2020 Results - Earnings Call Transcript

Shares of Alphatec Holdings (NASDAQ:ATEC) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year to ($0.27), which missed the estimate of ($0.21).

Alphatec Holdings: Q4 Earnings Insights

CARLSBAD, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2020, and recent corporate highlights.

ATEC Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Highlights

On Thursday, March 04, Alphatec Holdings (NASDAQ:ATEC) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Earnings Preview: Alphatec Holdings

CARLSBAD, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report fourth quarter and full year 2020 financial results on March 4, 2021, after the market close. The Company will host a live webcast the same day at 1:30 p.m. PT / 4:30 p.m. ET.

ATEC to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021

CARLSBAD, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company has relocated to its new headquarters in Carlsbad.

ATEC Opens New Headquarters with Substantially Increased Sales and Surgeon Education Capacity

Blue Bird

Fidus Investment

It's prudent for investors to keep an eye on a few stocks like Alphatec Holdings (ATEC), Fidus Investment (FDUS) and Blue Bird (BLBD) for stellar earnings acceleration.

3 Stocks to Watch Out for Earnings Acceleration in 2021

ADTRAN Holdings Inc

Apollo Medical Hlds

Donnelley Financial Solutions

Digi

We recommend a few lesser-known stocks that hold promise for high returns this year. ADTN, AMEH, ATEC, DFIN and DGII fit the bill.

5 Little-Known Stocks Under $20 Analysts Recommend Buying

CARLSBAD, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Jeff Black, Executive Vice President and Chief Financial Officer, will present virtually at the H.C. Wainwright BioConnect 2021 Conference, which will be held January 11 through 14, 2021.  The pre-recorded presentation will be accessible on demand for 90 days beginning January 11, 2021, at 6 A.M. ET via this link . The accompanying presentation materials will be available from the Investor Relations page of the Company's corporate website at www.atecspine.com.

ATEC to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

CARLSBAD, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that it has entered into an agreement to acquire EOS imaging, SA, for a purchase price of $79.7 million, plus the retirement debt of $37.2 million, in an all-cash transaction.

ATEC Continues to Advance Clinical Prowess with Renewed Agreement to Acquire EOS Imaging

Alphatec Holdings, Inc.'s (ATEC) CEO Pat Miles on Q3 2020 Results - Earnings Call Transcript

On Thursday, November 05, Alphatec Holdings (NASDAQ: ATEC) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

Preview: Alphatec Holdings's Earnings

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Alphatec (ATEC) Q3 Earnings Expected to Decline

Company announced blowout Q3 results with revenue growth accelerating well above 40%. Shares rallied hard on the news, effectively paving the way for a much- needed capital raise. Alphatec is now fully funded for at least the next two years.

Alphatec Holdings - Get Long Into Anticipated Strong Guidance On November 5 After Blowout Q3 Preannouncement

Elevates MIS posterior fixation option ality

ATEC Extends InVictus MIS Platform With Commercial Release of InVictus MIS Tower

CARLSBAD, Calif., Oct. 16, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 13,142,855 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 1,714,285 additional shares of common stock, at a public offering price of $8.75 per share, for total gross proceeds of approximately $115.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by ATEC.

ATEC Announces Closing of Public Stock Offering and Full Exercise of Underwriters' Option to Purchase Additional Stock

The company released preliminary third-quarter results.

Why Alphatec Holdings Stock Is Soaring Today

CARLSBAD, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today preliminary, unaudited financial results for the third quarter ended September 30, 2020.

ATEC Announces Preliminary Third Quarter 2020 Financial Results

CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial releases of two new solutions designed to elevate the ATEC transforaminal lumbar interbody fusion (TLIF) clinical experience. The Sigma Access System and the InVictus Modular Pedicle Screw are novel technologies that fully integrate with the SafeOp Neural InformatiX system, the SingleStep implant delivery system and IdentiTi TLIF implants, to enable a comprehensive, intelligently designed TLIF approach.

ATEC Announces Commercial Release of Distinct, Comprehensive TLIF Approach

Over 500 Initial Surgeries Successfully Performed

ATEC Announces Novel PTP Approach

Alphatec (ATEC) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Alphatec (ATEC) Looks Good: Stock Adds 5.8% in Session

CARLSBAD, Calif., Sept.  08, 2020  (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chief Executive Officer, will participate in the following virtual fireside chats:

Alphatec to Participate in Upcoming Investor Conferences

Alphatec Holdings, Inc. (ATEC) CEO Patrick Miles on Q2 2020 Results - Earnings Call Transcript

CARLSBAD, Calif., July  31, 2020  (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chief Executive Officer, will present virtually at the 40th Annual Canaccord Growth Conference on August 12, 2020, at 1 P.M. EDT.

News for Alphatec Hlds Stock (ATEC)